Home
  • Our Company
    • Biopharmaceutical Acceleration Model®
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Decentralized Solutions
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • AnswerSuite
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Full-Service Commercial
      • Health Economics and Outcomes Research
      • Medical Affairs Transformation
      • Medical Communications
      • Policy and Advocacy
      • Portfolio Strategy
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Selling Solutions
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Medical Affairs
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease and Vaccines
      • Ophthalmology
      • Respiratory
      • Women's Health
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Patient Voice
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • インサイト ハブ
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Standard Contractual Clauses for Suppliers
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series Remote Care
Trends
  • COVID-19
  • Decentralized Clinical Trials
  • Clinical Commercial Integration

Remote Care

December 1, 2020
Content 

 

Subscribe to our Newsletter

Remote Care

2021 Health Trends

Columns 
Content 
Image or Video 

Trends_2021_01.png

2021 Health Trends Remote Care
Content 

When the pandemic took hold, practices and research sites limited physical access to protect people while health systems and industry partners moved to rapidly scale digital and voice channels to maximize patient connectivity. Regulators and payers joined the cause to reduce friction and fuel reimbursement.

 

Even as that immediacy and urgency fade, healthcare leaders and patients alike have a changed expectation for a future that pivots off a connection, not an office or site. As we enter 2021, the rise, fall and reset of remote monitoring and commercial telemedicine will largely shape the future of care and drive how life sciences leaders engage and support patients and prescribers.  

Critical Questions
  • What will the new best practices be for how industry can support patients and professionals connecting across distance?
  • How can this new fluency consistently create access to trials for more patients and access to support for more patients?

Learn more: Download the deep dive trend report on Remote Care below.

Did You Know...

Columns 
Content 
Image or Video 

01_RemoteCare_01_v2.png

Remote Care Spark 1

300%: The number of practices offering telemedicine connectivity in the U.S. grew from 59% to 76% ​at the height of the 2020 wave of the pandemic.​

– Syneos Health, 2020​

Content 
Image or Video 

01_RemoteCare_02_v2.png

Remote Care Spark 2

Family Teledoc: The healthcare division of Chinese e-commerce giant JD.com recently launched a new service package ​that looks more like a traditional primary care program. ​As many as eight family members share a family doctor ​package that includes 24/7 immediate medical support from GPs and specialist medical consults within 48 hours.

– MobiHealthNews, 2020​

Implementing Remote Clinical Trial Monitoring to Ensure Continuity of Trials and Data Preservation – While Keeping Patients Safe
Enabled 
Download
Next

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chapters

Chapter:
1
Remote Care
Chapter:
2
The Race to Return Safe
Chapter:
3
Realigning in Real Time
Chapter:
4
Post-Surge Capacity
Chapter:
5
The Next Normal
Chapter:
6
Fast Launch; Long Tail

Pages

  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »
Branded Logo
Contact Us Today Share

Related Content

2021 Health Trend Series: Remote Care in 2021 and Beyond
July 1, 2021
Implementing Remote Clinical Trial Monitoring to Ensure Continuity of Trials and Data Preservation – While Keeping Patients Safe
April 3, 2020
Telemedicine Use and Field Force Engagement in the COVID-19 Era and Beyond
June 19, 2020
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. We support a diverse, equitable and inclusive culture. Contact Us

Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • 労働者派遣法に基づく情報公開
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2022 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Privacy Shield
  • Online Tracking Opt-Out